These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16353376)

  • 21. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).
    Walker JL; Wang SS; Schiffman M; Solomon D;
    Am J Obstet Gynecol; 2006 Aug; 195(2):341-8. PubMed ID: 16890545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells.
    Saqi A; Gupta PK; Erroll M; Babiac A; Blackmun D; Mansukhani M; Vazquez M
    Diagn Cytopathol; 2006 Mar; 34(3):235-9. PubMed ID: 16470857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cervical cancer prevention: the impact of HPV vaccination].
    Monsonégo J
    Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
    Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
    Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficient cytologic screening: selective and in combination with HPV test].
    Rubinstein E
    Lakartidningen; 2000 Jan; 97(4):371. PubMed ID: 10684236
    [No Abstract]   [Full Text] [Related]  

  • 26. The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment.
    Ronco G; Brezzi S; Carozzi F; Dalla Palma P; Giorgi-Rossi P; Minucci D; Naldoni C; Segnan N; Zappa M; Zorzi M; Cuzick J;
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S230-2. PubMed ID: 17822751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
    Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.
    Papa D; Moore Simas TA; Reynolds M; Melnitsky H
    J Low Genit Tract Dis; 2009 Apr; 13(2):66-71. PubMed ID: 19387125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [HPV test makes cytological examination more accurate. Cervical cancer can be discovered more efficiently].
    Andersson S; Hjerpe A; Johansson BC; Hagmar B
    Lakartidningen; 2007 Sep 26-Oct 2; 104(39):2797-9. PubMed ID: 17958005
    [No Abstract]   [Full Text] [Related]  

  • 30. [HPV testing--the effect must be evaluated prior to clinical use!].
    Persson E; Andrae B; Strander B
    Lakartidningen; 2002 May; 99(22):2552. PubMed ID: 12092058
    [No Abstract]   [Full Text] [Related]  

  • 31. Cervical cytology screening and evaluation.
    Noller KL
    Obstet Gynecol; 2005 Aug; 106(2):391-7. PubMed ID: 16055593
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cervix cancer screening can be cost-effective. Combination of vaginal smears and the HPV test should be even more beneficial].
    Bistoletti P; Ellström A; Dillner J; Sennfält K; Sparén P; Strander B
    Lakartidningen; 2005 Jun 13-26; 102(24-25):1874-6, 1878-9. PubMed ID: 16044766
    [No Abstract]   [Full Text] [Related]  

  • 33. Cervical cancer prevention for all Canadians.
    Sellors JW
    Can Fam Physician; 1999 Feb; 45():245-7, 252-4. PubMed ID: 10065291
    [No Abstract]   [Full Text] [Related]  

  • 34. Cervical cancer: new technologies target treatment strategies.
    Naper J
    Hosp Technol Ser; 1995 Aug; 14(8):1-2. PubMed ID: 10151286
    [No Abstract]   [Full Text] [Related]  

  • 35. Cervical cancer screening: are the 1989 recommendations still valid? National Workshop on Screening for Cancer of the Cervix.
    Parboosingh EJ; Anderson G; Clarke EA; Inhaber S; Kaegi E; Mills C; Mao Y; Root L; Stuart G; Stachenko S
    CMAJ; 1996 Jun; 154(12):1847-53. PubMed ID: 8653644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening.
    Smith RA; Cokkinides V; Brooks D; Saslow D; Brawley OW
    CA Cancer J Clin; 2010; 60(2):99-119. PubMed ID: 20228384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The use of HPV typing: the point of view of the virologist and the pathologist].
    Bergeron C
    Ann Pathol; 1999; 19(5 Suppl):S92-3. PubMed ID: 10599464
    [No Abstract]   [Full Text] [Related]  

  • 38. New way to detect cervical cancer.
    Can Nurse; 2001 May; 97(5):10. PubMed ID: 11865599
    [No Abstract]   [Full Text] [Related]  

  • 39. Risk-adapted multimodal laboratory cervical screening -- application of new technologies to cervical cancer prevention.
    Bollmann R; Bankfalvi A; Bollmann M
    Croat Med J; 2005 Jun; 46(3):361-7. PubMed ID: 15861512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Assessment of human papilloma virus (HPV) testing in primary screening for cervical cancer in France (May 2004). Gynecol Obstet Fertil 2005;33:357-360].
    Monsonego J
    Gynecol Obstet Fertil; 2005 Nov; 33(11):952-5. PubMed ID: 16243571
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.